Concordia (CXRX) Denies Takeover Discussions With Pernix (PTX); Medtronic (MDT) Sees Potential in Mazor Robotics (MZOR)

 

http://galaxystocks.com/wp-content/uploads/2016/05/Pernix_Therapeutics_PTX.jpg

Pernix Therapeutics Holdings Inc. (Nasdaq:PTX) stock closed in negative territory by 3.62% (or -$0.03) at $0.787 with a total volume of 7.92M shares traded on Monday

After the closing bell, pharmaceutical company Concordia International Corp. (Nasdaq:CXRX) has denied  speculation that it has held acquisition talks with Pernix Therapeutics.

Pernix recently delivered second quarter 2016 revenue of $36.7 million, representing a 13% increase sequentially

Pernix Therapeutics Holdings, which develops, manufactures, markets, and sells pharmaceutical products, has 85.12M Shares Outstanding, Market Capitalization (intraday) of $67.01M and PTX stock 52-week range is between $0.39 and $4.89 per share

*

http://galaxystocks.com/wp-content/uploads/2016/07/Mazor_Robotics_MZOR.jpg

Medical technology and services company Medtronic PLC (NYSE:MDT) disclosed in a regulatory filing ( SC 13G ) with the U.S. Securities and Exchange Commission (SEC) an 8.6% stake (1,958,684 ADS or 3,917,368 ordinary shares) in Mazor Robotics Ltd. (Nasdaq:MZOR).

Mazor Robotics reported earlier this month that second quarter 2016 revenue rose by 6% year-over-year to $8.3 million

MZOR stock finished Monday’s trading session at $23.35, up $0.25 (or +1.08%) and 77,605 of its shares changed hands during the day

Mazor Robotics, which develops and markets surgical guidance systems and complementary products, has 21.26M Shares Outstanding, Market Capitalization (intraday) of $491.04M and MZOR stock one-year range is from $8.31 to $24.79 per share

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/